Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
1.410
-0.010 (-0.70%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Lifeward Revenue
In the year 2024, Lifeward had annual revenue of $25.66M with 85.24% growth. Lifeward had revenue of $7.55M in the quarter ending December 31, 2024, with 9.60% growth.
Revenue (ttm)
$25.66M
Revenue Growth
+85.24%
P/S Ratio
0.48
Revenue / Employee
$320,788
Employees
80
Market Cap
15.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.66M | 11.81M | 85.24% |
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
LFWD News
- 6 days ago - Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market - GlobeNewsWire
- 5 weeks ago - FDA Issues Clearance for ReWalk 7 Exoskeleton - GlobeNewsWire
- 6 weeks ago - Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton - GlobeNewsWire
- 6 weeks ago - Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use - GlobeNewsWire
- 7 weeks ago - Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025 - GlobeNewsWire
- 2 months ago - Lifeward Announces CEO Transition - GlobeNewsWire